Literature DB >> 11402337

Function and regulation of AP-1 subunits in skin physiology and pathology.

P Angel1, A Szabowski, M Schorpp-Kistner.   

Abstract

The mouse skin has become the model of choice to study the regulation and function of AP-1 subunits in many physiological and pathological processes in vivo and in vitro. Genetically modified mice, in vitro reconstituted skin equivalents and epidermal cell lines were established, in which AP-1-regulated genetic programs of cell proliferation, differentiation and tumorigenesis can be analysed. Since the epidermis, as our interface with the environment, is subjected to radiation and injury, signal transduction pathways and critical AP-1 members regulating the mammalian stress response could be identified. Regulated expression of important components of the cytokine network, cell surface receptors and proteases, which orchestrate the process of wound healing has been found to rely on AP-1 activity. Here we review our current knowledge on the function of AP-1 subunits and AP-1 target genes in these fascinating fields of skin physiology and pathology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402337     DOI: 10.1038/sj.onc.1204380

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  120 in total

1.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Glucocorticoid receptors, epidermal homeostasis and hair follicle differentiation.

Authors:  Paloma Pérez
Journal:  Dermatoendocrinol       Date:  2011-07-01

3.  Identification of genes correlated with early-stage bladder cancer progression.

Authors:  Randolph Stone; Anita L Sabichi; Jennifer Gill; I-Ling Lee; Patrick Adegboyega; Michael S Dai; Raja Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

4.  c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Authors:  Jane Y Jin; Hengning Ke; Russell P Hall; Jennifer Y Zhang
Journal:  J Invest Dermatol       Date:  2011-02-03       Impact factor: 8.551

5.  In vitro evaluation of the effects of human umbilical cord extracts on human fibroblasts, keratinocytes, and melanocytes.

Authors:  Phuc Van Pham; Loan Thi-Tung Dang; Uyen Thanh Dinh; Huyen Thi-Thu Truong; Ba Ngoc Huynh; Dong Van Le; Ngoc Kim Phan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-26       Impact factor: 2.416

6.  Contribution of subcutaneous connective tissues to the epithelialization and cyst formation by the skin transplanted subcutaneously.

Authors:  Hajime Sawada; Hong-Ming Sheng; Yoji Hakamata; Michiyo Esaki; Asami Kita; Toyokazu Yoshida; Eiji Kobayashi
Journal:  Organogenesis       Date:  2004-10       Impact factor: 2.500

7.  The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.

Authors:  Jennifer Y Zhang; Maria Angelica Selim
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

8.  Bone marrow stromal cells, preadipocytes, and dermal fibroblasts promote epidermal regeneration in their distinctive fashions.

Authors:  Shigehisa Aoki; Shuji Toda; Takashi Ando; Hajime Sugihara
Journal:  Mol Biol Cell       Date:  2004-08-03       Impact factor: 4.138

9.  c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cells.

Authors:  Dongyun Zhang; Jingxia Li; Jimin Gao; Chuanshu Huang
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-14       Impact factor: 4.219

10.  Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.

Authors:  Satish B Cheepala; Weihong Yin; Zanobia Syed; Jennifer N Gill; Alaina McMillian; Heather E Kleiner; Mark Lynch; Rasiah Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Mol Cancer       Date:  2009-05-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.